Investigating the immune environment in pancreatic islets related to Type 2 Diabetes
Immune Landscape of Human Pancreatic Islets in Type 2 Diabetes
This study is looking at how certain fats in the body affect the immune system in people with and without Type 2 Diabetes, using special imaging to see how immune cells behave in the pancreas, and it also helps students from diverse backgrounds get involved in medical research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11039258 on NIH RePORTER |
What this research studies
This research focuses on understanding how lipid antigens influence immune responses in the context of Type 2 Diabetes (T2D). By examining human pancreatic islets, the study aims to identify how immune cells infiltrate and activate in individuals with and without T2D. The researchers will utilize advanced imaging techniques to visualize these immune interactions, which may reveal new insights into the chronic inflammation associated with T2D. Additionally, the project supports educational opportunities for underrepresented students in biomedical research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes as well as healthy individuals for comparative analysis.
Not a fit: Patients with other forms of diabetes or those who do not have any pancreatic or immune-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing or preventing Type 2 Diabetes by targeting immune responses.
How similar studies have performed: Previous research has indicated that understanding immune mechanisms in diabetes can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Nicholas, Dequina Angelina — University of California-Irvine
- Study coordinator: Nicholas, Dequina Angelina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.